Purchase Order W81K0022P0031
Award Date 12/30/21
Potential Completion Date 12/29/26
Potential Value $271K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Irwin, CA 92310, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $64,637.68 firm fixed-price purchase order to Werfen USA LLC for ACL Elite Pro Analyzers (coagulation testing equipment) and associated reagents, test kits, and controls. The contract was awarded on September 28, 2021, with an ultimate completion date of September 27, 2022, following a solicitation posted on September 14, 2021. No small business set-aside was utilized. The place of performance is Bedford, Massachusetts, where Werfen USA LLC manufactures in...
- The Defense Health Agency awarded a $430,739.50 purchase order to Werfen USA LLC on October 1, 2024, for reagents and coagulation analyzer cost-per-test services. The contract, structured as a firm fixed-price procurement with no set-aside designation, will be performed in Bedford, Massachusetts and is scheduled for completion by September 30, 2029. Werfen USA LLC, a Bedford-based manufacturer of in vitro diagnostic equipment and laboratory reagents, will deliver coagulation testing...
- The Defense Health Agency awarded a $50,489.84 delivery order to Werfen USA LLC on September 28, 2024, for the provision of two ACL Elite Pro coagulation analyzers and associated reagents to support cost-per-reportable-result testing at Naval Hospital Twentynine Palms. The award is structured as a firm fixed-price contract with an ultimate completion date of August 31, 2025, and is issued under the Critical Analyzers, Laboratory GSA Schedule (FSS-66-III). No set-aside designation was applied...
- The Defense Health Agency awarded a $108,657.52 delivery order to Werfen USA LLC for blood coagulation analyzer and reagents with a performance period from October 1, 2025 through September 30, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, and performance will occur at a location in Fayetteville, North Carolina. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory...
- The Defense Health Agency awarded a $64,637.68 firm fixed-price delivery order to Werfen USA LLC for two ACL Elite Pro Analyzers with associated consumables and reagents. The delivery order was executed on September 28, 2022, with an ultimate completion date of September 27, 2023, and is set to be performed at Twentynine Palms Marine Corps Base in California. This award was issued under the Critical Analyzers, Laboratory General Services Administration Schedule (FSS-66-III) and carries no...
- The Defense Health Agency awarded a $714.7K firm fixed-price purchase order to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, for blood coagulation testing supplies and support services. This contract, which commenced on October 1, 2020, and extends through September 30, 2025, involves the delivery of two fully automated benchtop coagulation analyzer systems capable of performing comprehensive assays including...
- Werfen USA LLC was awarded a $65,570.76 firm fixed-price delivery order by the Defense Health Agency for ACL Elite Pro Analyzers (CPR) with an ultimate completion date of September 27, 2024. The delivery order, issued without set-aside designation, is for performance at Marine Corps Base Twentynine Palms, California. This award represents a task order issued under Werfen's existing Critical Analyzers, Laboratory GSA Schedule contract (FSS-66-III), which provides the Defense Health Agency with...
- The Defense Health Agency awarded a definitive firm fixed-price contract to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, for the provision of coagulation analyzers and associated reagents. The contract, awarded on April 1, 2026, carries a ceiling value of $271,477.50 and extends through March 31, 2031. No set-aside designation was utilized in this procurement. Werfen USA LLC will perform the work at its facilities in Bedford,...
- The U.S. Medical Command awarded a $176,529.60 firm fixed-price purchase order to Werfen USA LLC on October 1, 2021, for the lease of ACL Elite diagnostic equipment with an ultimate completion date of September 30, 2022. The contract, issued without small business set-aside designation, was performed at Fort Johnson South, Louisiana. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer and supplier of in vitro diagnostic equipment and clinical laboratory instrumentation, specializes in...
- The Defense Health Agency awarded a $228,353.45 firm fixed-price purchase order to Werfen USA LLC for blood typing reagents, with a completion deadline of September 30, 2027. This award involved a novation agreement reflecting a change of name for the contractor. The contract is not set-aside designated and will be performed in El Paso, Texas. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory consumables, is a full-sized...